Aktienanalyse wird geladen …
ELV · NYSE · Health Insurance · USA
398,25 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Nettomarge | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | 199,13 Mrd. | 5,66 Mrd. | 25,21 $ | 224,6 Mio. | 0,7 Mio · 0,3 % | 9 Mio · 4 % | 2,8 % | 1,23 $ | 6,84 $ |
| 2024 | 177,01 Mrd. | 5,98 Mrd. | 25,68 $ | 232,9 Mio. | 0,5 Mio · 0,2 % | 5 Mio · 2,1 % | 3,4 % | 0,82 $ | 6,52 $ |
| 2023 | 171,34 Mrd. | 5,99 Mrd. | 25,22 $ | 237,4 Mio. | 0,7 Mio · 0,3 % | 6,1 Mio · 2,6 % | 3,5 % | 1,22 $ | 5,92 $ |
| 2022 | 156,6 Mrd. | 5,89 Mrd. | 24,28 $ | 242,8 Mio. | 0,7 Mio · 0,3 % | 4,7 Mio · 1,9 % | 3,8 % | 1,09 $ | 5,12 $ |
| 2021 | 138,64 Mrd. | 6,16 Mrd. | 24,95 $ | 246,8 Mio. | 0,6 Mio · 0,3 % | 8,1 Mio · 3,3 % | 4,4 % | 1,03 $ | 4,52 $ |
| 2020 | 121,87 Mrd. | 4,57 Mrd. | 17,98 $ | 254,3 Mio. | 0,7 Mio · 0,3 % | 6,7 Mio · 2,6 % | 3,8 % | 1,11 $ | 3,80 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge |
|---|---|---|---|---|---|
| Q2 2026 | 50,47 Mrd. | 1,46 Mrd. | 6,71 $ | 217,9 Mio. | 2,9 % |
| Q1 2026 | 50,18 Mrd. | 1,76 Mrd. | 8,00 $ | 220,4 Mio. | 3,5 % |
| Q4 2025 | 49,75 Mrd. | 547 Mio. | 2,44 $ | 221,8 Mio. | 1,1 % |
| Q3 2025 | 50,71 Mrd. | 1,19 Mrd. | 5,32 $ | 223,7 Mio. | 2,3 % |
| Q2 2025 | 49,78 Mrd. | 1,74 Mrd. | 7,72 $ | 225,8 Mio. | 3,5 % |
| Q1 2025 | 48,89 Mrd. | 2,18 Mrd. | 9,61 $ | 227,2 Mio. | 4,5 % |
| Q4 2024 | 45,44 Mrd. | 418 Mio. | 1,86 $ | — | 0,9 % |
| Q3 2024 | 45,11 Mrd. | 1,02 Mrd. | 4,36 $ | 233,1 Mio. | 2,3 % |
Elevance Health, Inc. is a U.S. health benefits and health services company headquartered in Indianapolis, Indiana. It provides a broad range of health insurance products and related services for individuals, employers, and government-sponsored programs, with offerings that include commercial medical coverage, Medicare and Medicaid plans, dental, vision, behavioral health, and pharmacy benefits. The company operates through Health Benefits, CarelonRx, Carelon Services, and Corporate & Other, combining insurance operations with care management and healthcare enablement services. Elevance Health serves as a major participant in managed care, helping coordinate medical coverage, administrative services, and integrated care solutions across the U.S. healthcare system. Its portfolio is designed to support members, providers, and employer groups through a whole-health approach that links benefits, clinical support, and pharmacy services.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest ELV und jede andere Aktie unbegrenzt.